Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy
- PMID: 12131292
Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy
Abstract
Purpose: The initiation of prostate specific antigen (PSA) testing has led to increased public awareness, early detection and a stage shift in prostate cancer. We have previously reported that black American men have worse disease-free survival independently of pathological or clinical factors. We tested the stage shift effects on disease-free survival in our cohort of patients treated with radical prostatectomy.
Materials and methods: A total of 1,042 consecutive patients underwent radical prostatectomy performed by Wayne State University full-time faculty. The cohort was divided by the year of surgery as before (585 men in group 1) or after (457 in group 2) 1996. Clinicopathological and disease-free survival data were obtained from the Karmanos Cancer Institute multidisciplinary prostate cancer database.
Results: Improvements in clinical stage, preoperative PSA and biopsy Gleason score were observed in group 2 (p = 0.0001). Pathological organ confined disease increased in group 2 versus 1 in the 2 races, including 89 of 153 (58%) from 66 of 178 (37%) in black men and 189 of 304 (62%) from 194 of 407 (48%) in white men (p = 0.003 and 0.001, respectively). Calculated cancer recurrence-free median probability in group 1 at 42 months was 81% and 68% in white and black men, respectively (log rank test p = 0.001). These differences became insignificant in group 2 patients at 42 months with a median probability of 90% and 88% in white and black men, respectively (log rank test p = 0.39), representing a net increase in disease-free survival of 20% in black men. Specimen Gleason score, PSA and pathological stage were independent predictors of survival in the 2 groups. In contrast, race was an independent predictor only in group 1.
Conclusions: The increased rate of pathological organ confined disease is translating into improved disease-free survival rates. These early data suggest that the survival gap in black and white American men is narrowing and may become statistically insignificant.
Similar articles
-
Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.J Urol. 2007 Oct;178(4 Pt 1):1271-6. doi: 10.1016/j.juro.2007.05.127. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698101
-
Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.Urology. 2000 Feb;55(2):246-51. doi: 10.1016/s0090-4295(99)00436-7. Urology. 2000. PMID: 10688088
-
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.JAMA. 1995 Oct 25;274(16):1277-81. JAMA. 1995. PMID: 7563532
-
Pathology of premalignant lesions and carcinoma of the prostate in African-American men.Semin Urol Oncol. 1998 Nov;16(4):214-20. Semin Urol Oncol. 1998. PMID: 9858328 Review.
-
Race and serum prostate-specific antigen levels: current status and future directions.Semin Urol Oncol. 1998 Nov;16(4):207-13. Semin Urol Oncol. 1998. PMID: 9858327 Review.
Cited by
-
Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.BMC Urol. 2014 Dec 11;14:98. doi: 10.1186/1471-2490-14-98. BMC Urol. 2014. PMID: 25495177 Free PMC article.
-
Comparing the outcomes of robotic assisted radical prostatectomy in black and white men: Experience of a high-volume center.Int Braz J Urol. 2022 Jan-Feb;49(1):123-135. doi: 10.1590/S1677-5538.IBJU.2022.9979. Int Braz J Urol. 2022. PMID: 36512460 Free PMC article.
-
Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer.Urology. 2009 Mar;73(3):624-30. doi: 10.1016/j.urology.2008.09.081. Epub 2009 Jan 23. Urology. 2009. PMID: 19167034 Free PMC article.
-
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).J Urol. 2012 Oct;188(4):1164-9. doi: 10.1016/j.juro.2012.06.046. Epub 2012 Aug 22. J Urol. 2012. PMID: 22921015 Free PMC article.
-
From bench to bedside: the realities of reducing global prostate cancer disparity in black men.Ecancermedicalscience. 2014 Aug 28;8:458. doi: 10.3332/ecancer.2014.458. eCollection 2014. Ecancermedicalscience. 2014. PMID: 25228914 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous